tiprankstipranks
Trending News
More News >
Eli Lilly And Company (DE:LLY)
NYSE:LLY

Compare Eli Lilly & Co (LLY) vs. Competitors

Compare
192 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Eli Lilly & Co
€918.00
€862.46B
51.14
19.13%
18 Buy
2 Hold
0 Sell
Strong Buy
AstraZeneca
$93.63
$296.92B
31.19
40.29%
5 Buy
0 Hold
0 Sell
Strong Buy
Johnson & Johnson
$205.75
$492.44B
19.73
44.83%
13 Buy
7 Hold
0 Sell
Moderate Buy
Merck & Company
$109.19
$274.34B
14.62
10.02%
11 Buy
5 Hold
0 Sell
Moderate Buy
Novartis
$141.82
$272.03B
19.17
42.77%
1 Buy
4 Hold
1 Sell
Hold
AbbVie
$220.04
$388.97B
166.06
27.95%
15 Buy
8 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:LLY
Eli Lilly & Co
918.00
199.98
27.85%
AZN
AstraZeneca
93.63
29.60
46.23%
JNJ
Johnson & Johnson
209.72
69.27
49.32%
MRK
Merck & Company
109.19
13.15
13.69%
NVS
Novartis
141.82
45.38
47.05%
ABBV
AbbVie
220.04
50.42
29.73%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts